Global Amantadine HCl Oral Market Insights, Forecast to 2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Amantadine HCl Oral Quarterly Market Size Analysis
- 2.1 Amantadine HCl Oral Business Impact Assessment - COVID-19
- 2.1.1 Global Amantadine HCl Oral Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Amantadine HCl Oral Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Amantadine HCl Oral Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Amantadine HCl Oral Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Amantadine HCl Oral Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Amantadine HCl Oral Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Amantadine HCl Oral Market
- 3.5 Key Manufacturers Amantadine HCl Oral Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Amantadine HCl Oral Segments, By Type
- 4.1 Introduction
- 1.4.1 Tablet
- 1.4.2 Capsules
- 1.4.3 Syrup
- 4.2 By Type, Global Amantadine HCl Oral Market Size, 2019-2021
- 4.2.1 By Type, Global Amantadine HCl Oral Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Amantadine HCl Oral Price, 2020-2021
5 Impact of Covid-19 on Amantadine HCl Oral Segments, By Application
- 5.1 Overview
- 5.5.1 Parkinson's disease
- 5.5.2 Influenza
- 5.2 By Application, Global Amantadine HCl Oral Market Size, 2019-2021
- 5.2.1 By Application, Global Amantadine HCl Oral Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Amantadine HCl Oral Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Zydus Pharmaceuticals
- 7.1.1 Zydus Pharmaceuticals Business Overview
- 7.1.2 Zydus Pharmaceuticals Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Product Introduction
- 7.1.4 Zydus Pharmaceuticals Response to COVID-19 and Related Developments
- 7.2 Mylan
- 7.2.1 Mylan Business Overview
- 7.2.2 Mylan Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.2.3 Mylan Amantadine HCl Oral Product Introduction
- 7.2.4 Mylan Response to COVID-19 and Related Developments
- 7.3 Teva
- 7.3.1 Teva Business Overview
- 7.3.2 Teva Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.3.3 Teva Amantadine HCl Oral Product Introduction
- 7.3.4 Teva Response to COVID-19 and Related Developments
- 7.4 Vertical Pharmaceuticals
- 7.4.1 Vertical Pharmaceuticals Business Overview
- 7.4.2 Vertical Pharmaceuticals Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Product Introduction
- 7.4.4 Vertical Pharmaceuticals Response to COVID-19 and Related Developments
- 7.5 Adamas Pharmaceuticals
- 7.5.1 Adamas Pharmaceuticals Business Overview
- 7.5.2 Adamas Pharmaceuticals Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Product Introduction
- 7.5.4 Adamas Pharmaceuticals Response to COVID-19 and Related Developments
- 7.6 Upsher-Smith
- 7.6.1 Upsher-Smith Business Overview
- 7.6.2 Upsher-Smith Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.6.3 Upsher-Smith Amantadine HCl Oral Product Introduction
- 7.6.4 Upsher-Smith Response to COVID-19 and Related Developments
- 7.7 Sandoz
- 7.7.1 Sandoz Business Overview
- 7.7.2 Sandoz Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.7.3 Sandoz Amantadine HCl Oral Product Introduction
- 7.7.4 Sandoz Response to COVID-19 and Related Developments
- 7.8 Mikart Pharmaceuticals
- 7.8.1 Mikart Pharmaceuticals Business Overview
- 7.8.2 Mikart Pharmaceuticals Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Product Introduction
- 7.8.4 Mikart Pharmaceuticals Response to COVID-19 and Related Developments
- 7.9 Pharmaceutical Associates, Inc. (PAI)
- 7.9.1 Pharmaceutical Associates, Inc. (PAI) Business Overview
- 7.9.2 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product Introduction
- 7.9.4 Pharmaceutical Associates, Inc. (PAI) Response to COVID-19 and Related Developments
- 7.10 Wockhardt Bio AG
- 7.10.1 Wockhardt Bio AG Business Overview
- 7.10.2 Wockhardt Bio AG Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.10.3 Wockhardt Bio AG Amantadine HCl Oral Product Introduction
- 7.10.4 Wockhardt Bio AG Response to COVID-19 and Related Developments
- 7.11 CMP Pharma
- 7.11.1 CMP Pharma Business Overview
- 7.11.2 CMP Pharma Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.11.3 CMP Pharma Amantadine HCl Oral Product Introduction
- 7.11.4 CMP Pharma Response to COVID-19 and Related Developments
- 7.12 Bionpharma
- 7.12.1 Bionpharma Business Overview
- 7.12.2 Bionpharma Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.12.3 Bionpharma Amantadine HCl Oral Product Introduction
- 7.12.4 Bionpharma Response to COVID-19 and Related Developments
- 7.13 Graviti Pharma
- 7.13.1 Graviti Pharma Business Overview
- 7.13.2 Graviti Pharma Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.13.3 Graviti Pharma Amantadine HCl Oral Product Introduction
- 7.13.4 Graviti Pharma Response to COVID-19 and Related Developments
- 7.14 Alembic Pharmaceuticals
- 7.14.1 Alembic Pharmaceuticals Business Overview
- 7.14.2 Alembic Pharmaceuticals Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.14.3 Alembic Pharmaceuticals Amantadine HCl Oral Product Introduction
- 7.14.4 Alembic Pharmaceuticals Response to COVID-19 and Related Developments
- 7.15 Strides Pharma
- 7.15.1 Strides Pharma Business Overview
- 7.15.2 Strides Pharma Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.15.3 Strides Pharma Amantadine HCl Oral Product Introduction
- 7.15.4 Strides Pharma Response to COVID-19 and Related Developments
- 7.16 Heritage Pharmaceuticals
- 7.16.1 Heritage Pharmaceuticals Business Overview
- 7.16.2 Heritage Pharmaceuticals Amantadine HCl Oral Quarterly Production and Revenue, 2020
- 7.16.3 Heritage Pharmaceuticals Amantadine HCl Oral Product Introduction
- 7.16.4 Heritage Pharmaceuticals Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Amantadine HCl Oral Supply Chain Analysis
- 8.1.1 Amantadine HCl Oral Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Amantadine HCl Oral Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Amantadine HCl Oral Distribution Channels
- 8.2.2 Covid-19 Impact on Amantadine HCl Oral Distribution Channels
- 8.2.3 Amantadine HCl Oral Distributors
- 8.3 Amantadine HCl Oral Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Amantadine HCl Oral, including the following market information:
Global Amantadine HCl Oral Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Amantadine HCl Oral Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Amantadine HCl Oral Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Amantadine HCl Oral Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)
Key market players
Major competitors identified in this market include Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals, Pharmaceutical Associates, Inc. (PAI), Wockhardt Bio AG, CMP Pharma, Bionpharma, Graviti Pharma, Alembic Pharmaceuticals, Strides Pharma, Heritage Pharmaceuticals, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Tablet
Capsules
Syrup
Based on the Application:
Parkinson's disease
Influenza